BioSpace News Archive

Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) the last required technical section to support approval of Jaguar’s oral plant-based drug candidate Canalevia™ (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea (CID) in dogs.

Spain’s No. 1 dermatological company, ISDIN, announces the results from their consumer survey on sunscreen habits that collected data from a sample of over 102,000 consumers in the U.S. and Europe.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the closing of its previously announced underwritten public offering of 16,675,000 shares of its common stock at a public offering price of $13.00 per share, which included the full exercise of the underwriters’ option to purchase up to an additional 2,175,000 shares of common stock.

Asymptomatic bacteriuria is defined as the isolation of a substantial count of bacteria in voided urine specimen obtained from an individual who does not show any symptoms and signs of urinary tract infection.

Cerner Corporation® (NASDAQ: CERN), a global health care technology company, announced it has recently joined non-profit Testing for America and others, including the Thurgood Marshall College Fund (TMCF) and The United Negro College Fund (UNCF), to support Historically Black Colleges and Universities’ (HBCUs) efforts to offer rapid, consistent and affordable COVID-19 testing for students, faculty and staff.

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it has executed the definitive supply agreement provided for in the previously announced binding term sheet agreement with the Israeli Ministry of Health,

PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in which NIAID will assess the efficacy of PMC-403, a novel Tie2-activating antibody with a unique mode of action, for the treatment of Systemic Capillary Leak Syndrome (SCLS, Clarkson Disease).

During National Adult Immunization Week, the American Lung Association reminds adults that there are CDC-recommended vaccines for all age groups

Genosity Inc., announced today that it has received CLIA approval for its tumor exome and liquid biopsy cancer monitoring platform, AsTra (Assessment and Tracking), designed to identify a patient’s unique tumor molecular profile that can be used for ongoing, personalized Minimal Residual Disease (MRD) monitoring.

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer. I